title: Dermatophytosis during anti-TNF-α monoclonal antibody therapy.
authors.forename: Federico
authors.initials: F
authors.lastname: Bardazzi
authors.forename: Riccardo
authors.initials: R
authors.lastname: Balestri
authors.forename: Giulia
authors.initials: G
authors.lastname: Rech
authors.forename: Angela
authors.initials: A
authors.lastname: Antonucci
authors.forename: Annalisa
authors.initials: A
authors.lastname: Patrizi
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000473:pathology; D014005:Tinea / Q000139:chemically induced* / Q000175:diagnosis*; D014249:Trichophyton / Q000302:isolation & purification*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha